{
 "drug": "Ritonavir Oral Powder",
 "asOf": "2026-08-25",
 "status": "discontinuing",
 "since": "07/24/2026",
 "dayN": 32,
 "cat": "Antiviral",
 "companies": [
  "AbbVie Inc."
 ],
 "reasons": [],
 "records": [
  {
   "discontinued_date": "07/24/2026",
   "update_type": "New",
   "initial_posting_date": "07/24/2026",
   "package_ndc": "0074-3399-30",
   "generic_name": "Ritonavir Oral Powder",
   "contact_info": "800-633-9110",
   "related_info": "Discontinuation of the manufacture of the drug",
   "openfda": {
    "application_number": [
     "NDA209512"
    ],
    "brand_name": [
     "NORVIR"
    ],
    "generic_name": [
     "RITONAVIR"
    ],
    "manufacturer_name": [
     "AbbVie Inc."
    ],
    "product_ndc": [
     "0074-3399",
     "0074-3333",
     "0074-1940",
     "0074-2340"
    ],
    "product_type": [
     "HUMAN PRESCRIPTION DRUG"
    ],
    "route": [
     "ORAL"
    ],
    "substance_name": [
     "RITONAVIR"
    ],
    "rxcui": [
     "152971",
     "199249",
     "900575",
     "900577",
     "1926066",
     "1926069"
    ],
    "spl_id": [
     "08f28b14-eabc-4a9a-b066-d8eda837e9e4"
    ],
    "spl_set_id": [
     "2849298e-de6e-47bb-8194-56e075b33fc3"
    ],
    "package_ndc": [
     "0074-3333-30",
     "0074-1940-63",
     "0074-3399-30",
     "0074-2340-30"
    ],
    "nui": [
     "N0000000246",
     "N0000191001",
     "N0000175889",
     "N0000190114",
     "N0000182137",
     "N0000185607",
     "N0000190118",
     "N0000185503",
     "N0000190113",
     "N0000182141",
     "N0000191266",
     "N0000185507",
     "N0000187064",
     "N0000190117"
    ],
    "pharm_class_moa": [
     "HIV Protease Inhibitors [MoA]",
     "Cytochrome P450 3A Inhibitors [MoA]",
     "Cytochrome P450 2D6 Inhibitors [MoA]",
     "Cytochrome P450 2C19 Inducers [MoA]",
     "Cytochrome P450 3A Inducers [MoA]",
     "P-Glycoprotein Inhibitors [MoA]",
     "Breast Cancer Resistance Protein Inhibitors [MoA]",
     "Cytochrome P450 3A4 Inhibitors [MoA]",
     "Cytochrome P450 1A2 Inducers [MoA]",
     "Cytochrome P450 2C9 Inducers [MoA]",
     "Cytochrome P450 2B6 Inducers [MoA]",
     "UDP Glucuronosyltransferases Inducers [MoA]"
    ],
    "pharm_class_epc": [
     "Cytochrome P450 3A Inhibitor [EPC]",
     "Protease Inhibitor [EPC]"
    ],
    "unii": [
     "O3J8G9O825"
    ]
   },
   "update_date": "07/24/2026",
   "therapeutic_category": [
    "Antiviral"
   ],
   "dosage_form": "Oral Powder",
   "presentation": "Norvir, Oral Powder, 100 mg (NDC 0074-3399-30)",
   "company_name": "AbbVie Inc.",
   "status": "To Be Discontinued"
  }
 ]
}